Clinical Trial Update: 68Ga-PSMA PET in the Renal Cell Carcinoma [NA]

View source ↗

Summary

A clinical trial is evaluating 68Ga-PSMA PET imaging for renal cell carcinoma with metastases and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• 68Ga-PSMA PET tracer (Gallium-68 PSMA tracer)

Snippet

Sponsor: Xijing Hospital | Conditions: Renal Cancer, Metastases | NA | Status: RECRUITING